Valania Brian reported grant involving 4,800 derivative units of Mitesco, Inc. at $400.00 for $1.92M on Jul 10, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
CEO and CFO
CEO and CFO
Filed Aug 24, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$1,920,000Shares × reported price
Shares traded
4,800Series X Pref.
Price per share
$400.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
7,200Direct
Trade date
Jul 10, 2026Grant
Filed
Aug 24, 2026, 5:32 PM ET45-day reporting delay
Accession
0001185185-26-003695Code A · Transaction 84936
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Jul 29, 2024Grant200,000$0.25$50,000Trade 84932
Jul 21, 2026Grant221,078$0.08$17,686.24Trade 84933
Aug 3, 2026Grant3,000,000$0.04$105,000Trade 84934
May 1, 2026Grant2,400$400.00$960,000Trade 84935
5 transaction rows in this filing. Joint filers share the same rows.

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 45 calendar days after the transaction date.

MITI price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
MITI · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Aug 31, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Footnotes in full

F1: The Series X Preferred Stock has no conversion rights, is not exercisable, has no expiration date, and has no shares of Common Stock underlying it.